Notice that in the cancer lines used for our experimental verifications the most frequent driver and gate-keeper mutations / alterations are indeed present (in an order of a decreasing frequency of occurrence in CRC: TP53; APC; KRAS; PTEN; SMAD4; PIK3CA; BRAF; CDH1). Here, TP53 is linked to colorectal carcinoma.